As per Economic Times, the United States has sharply reduced import tariffs on Indian goods — cutting them from 50% to 18%. This significant reduction is expected to transform India’s prospects in exporting medical devices to the US market.
Enhanced Price Competitiveness
With lower tariffs in place, Indian medical devices become much more price-competitive compared to products from other countries, especially China. Previously, Chinese medical device exports faced higher duties, often in the 30%+ range under Section 301 trade penalties. In contrast, Indian devices now face an 18% duty, giving them a clear cost advantage.
Because of this tariff gap, Indian manufacturers are positioned to win more orders in the US, particularly for products like syringes, needles, and other basic medical accessories.
Broader Market Access and Growth Opportunities
In addition, the tariff cut will accelerate market access by lowering the overall costs of exporting to one of the world’s largest healthcare markets. Industry leaders have called this a “game changer” for Indian producers.
For example, the Association of Indian Medical Device Industry (AiMeD) has highlighted that this change will attract more investments, boost global competitiveness, and create jobs. Moreover, it could help Indian companies expand their global footprint beyond traditional export destinations.
Strategic Advantage Amid Shifting Supply Chains
Finally, analysts note that this tariff reduction arrives at a time when many global buyers are seeking alternatives to China (often referred to as the “China+1” strategy). The relative tariff advantage for Indian goods could therefore play into broader supply-chain diversification trends, helping India lock in longer-term business with US buyers.